Aubrey de Grey, Limits to Human Longevity: New Ways to Analyze Data and New Ways to Predict the Future - Descripción
There is intense interest these days in the “oldest old” - the individuals who define the extreme limits of how long people can live. Much of the study of these exceptional people revolves around validation of longevity claims, and sophisticated methods and conventions for verification have been developed. But then what? First, by definition the oldest old are few in number, which limits what we can say statistically about things like the change in mortality risk with age. Second, we would like to identify reliable ways to predict the rate at which the greatest ages will increase in the future, which has been very unsuccessful so far. I will outline the ways in which validation is conducted, and then I will present a new approach to the statistical analysis of such data that greatly increases the statistical power that can be extracted from these small datasets. Finally I will offer some thoughts on how we can and cannot reliably predict future trends in extreme longevity.
Comments are disabled for this video.
Aubrey de Grey, Limits to Human Longevity: New Ways to Analyze Data and New Ways to Predict the Future - Biografía
Dr. Aubrey de Grey is a biomedical gerontologist based in Mountain View, California, USA, and is the Chief Science Officer of SENS Research Foundation, a California-based biomedical research charity that performs and funds laboratory research dedicated to combating the aging process. He is also Editor-in-Chief of , the world’s highest-impact peerreviewed journal focused on intervention in aging. He received his BA in computer science and PhD in biology from the University of Cambridge. His research interests encompass the characterization of all the types of self-inflicted cellular and molecular damage that constitute mammalian aging and the design of interventions to repair and/or obviate that damage. Dr. de Grey is a Fellow of both the Gerontological Society of America and the American Aging Association, and sits on the editorial and scientific advisory boards of numerous journals and organizations. He is a highly sought-after speaker who gives 40-50 invited talks per year at scientific conferences, universities, companies in areas ranging from pharma to life insurance, and to the public.